RRQ-15832-37454
4 vaccinations
3 coded responses
30 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 130 / NY
- Registered
- 2021-03-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-04
Dose 1 — Pfizer-BioNTech
-
2021-02-25
Dose 2 — Pfizer-BioNTech
-
2021-03-06
Registered in v-safe
- 2021-03-06
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-05-27
- 2021-08-26
-
2021-10-01
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-01
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-03
- 2021-10-04
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Headache, Diarrhea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-11-12
-
2021-12-31
Survey response — 3 months, dose 3MedDRA: Nasal congestion, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend schoolFree text: I have had a stuffy nose. I tested negative for covid.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-01
-
2022-09-10
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-25
-
2022-10-01
Survey response — day 21, dose 4MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-10-08
- 2022-10-15
- 2022-10-22
- 2022-12-10
-
2023-03-11
Survey response — 6 months, dose 4MedDRA: Headache, Oropharyngeal pain, Rhinorrhoea — Feeling: Good · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-04 | Pfizer-BioNTech | |
| 2 | 2021-02-25 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | Flu |
| 4 | 2022-09-10 | Pfizer-BioNTech | Flu |
Free text
Release 10 — 3 months, dose 3
Symptoms: I have had a stuffy nose. I tested negative for covid.
Release 12 — day 21, dose 4
Symptoms: Runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release